Agrow is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EU approval nears for two ais

Proposals to grant full EU approval to two new fungicides, BASF’s ametoctradin (trade-marked as Initium) and Syngenta’s mandipropamid, have been voted through by the EU Standing Committee on the Food Chain and Animal Health. Once confirmed by the European Commission, they will be added to the list of approved active ingredients in the EU agrochemical registration Regulation (1107/2009). Applications were submitted in 2008 for ametoctradin and in 2005 for mandipropamid. Both ais had their three-year national provisional approvals extended to allow more time for the EU approval process to be completed ( Agrow No 652, p 10 and No 622, p 13). Ametoctradin holds provisional approvals in Belgium, Germany, Estonia, France, Hungary, Latvia, Lithuania, the Netherlands and Romania, with applications submitted in Austria, Ireland, Italy, Slovenia and the UK. Mandipropamid holds provisional approvals in 26 member states, and has an application under evaluation in Spain.

Advertisement

Topics

What to read next

Advertisement
UsernamePublicRestriction

Register

AG007206

Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel